ArTS Archivio della ricerca di Trieste

SALTON, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.438
AS - Asia 5.634
EU - Europa 5.350
SA - Sud America 672
AF - Africa 203
OC - Oceania 67
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 18.369
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.141
IT - Italia 1.934
SG - Singapore 1.857
CN - Cina 1.161
PL - Polonia 850
VN - Vietnam 664
HK - Hong Kong 545
BR - Brasile 513
DE - Germania 407
KR - Corea 349
BD - Bangladesh 336
GB - Regno Unito 309
SE - Svezia 306
FR - Francia 298
NL - Olanda 262
FI - Finlandia 217
RU - Federazione Russa 176
IN - India 154
CA - Canada 145
IE - Irlanda 107
MX - Messico 99
BG - Bulgaria 92
TR - Turchia 82
JP - Giappone 69
AT - Austria 66
MA - Marocco 63
CH - Svizzera 59
AU - Australia 58
ES - Italia 50
ID - Indonesia 49
IQ - Iraq 45
AR - Argentina 44
PK - Pakistan 36
SA - Arabia Saudita 35
UA - Ucraina 35
BE - Belgio 34
PH - Filippine 34
ZA - Sudafrica 33
TW - Taiwan 32
CO - Colombia 29
TH - Thailandia 25
EC - Ecuador 21
UZ - Uzbekistan 21
IR - Iran 20
SI - Slovenia 20
SN - Senegal 20
CL - Cile 19
EG - Egitto 19
GR - Grecia 19
CZ - Repubblica Ceca 17
PT - Portogallo 17
VE - Venezuela 17
IL - Israele 14
AE - Emirati Arabi Uniti 12
AZ - Azerbaigian 12
RO - Romania 12
TN - Tunisia 12
LT - Lituania 11
MY - Malesia 11
JO - Giordania 10
CR - Costa Rica 9
DK - Danimarca 9
OM - Oman 9
PA - Panama 9
KE - Kenya 8
LK - Sri Lanka 8
NZ - Nuova Zelanda 8
PY - Paraguay 8
AO - Angola 7
DZ - Algeria 7
ET - Etiopia 7
KZ - Kazakistan 7
TT - Trinidad e Tobago 7
UY - Uruguay 7
BO - Bolivia 6
CI - Costa d'Avorio 6
HU - Ungheria 6
AL - Albania 5
BY - Bielorussia 5
GT - Guatemala 5
HN - Honduras 5
KG - Kirghizistan 5
LB - Libano 5
NG - Nigeria 5
NO - Norvegia 5
NP - Nepal 5
PE - Perù 5
JM - Giamaica 4
PS - Palestinian Territory 4
SK - Slovacchia (Repubblica Slovacca) 4
YE - Yemen 4
DO - Repubblica Dominicana 3
EU - Europa 3
LU - Lussemburgo 3
LY - Libia 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
BZ - Belize 2
CG - Congo 2
CM - Camerun 2
Totale 18.321
Salva come PNG Salva come JPEG
Città #
Singapore 1.045
Ashburn 871
Warsaw 731
San Jose 686
Hong Kong 520
Chandler 440
Council Bluffs 343
Trieste 337
Hefei 336
Seoul 332
Beijing 270
Ho Chi Minh City 196
Los Angeles 194
Boardman 172
Dallas 157
Fairfield 157
Hanoi 157
London 139
Chicago 134
Milan 132
New York 126
Columbus 112
Lauterbourg 112
Santa Clara 107
Helsinki 102
Frankfurt am Main 94
Princeton 94
Dublin 93
Seattle 92
Zgierz 92
The Dalles 90
Sofia 89
Houston 87
Woodbridge 85
Wilmington 83
Munich 81
Moscow 80
Rome 78
Lappeenranta 69
Ann Arbor 66
São Paulo 60
Buffalo 58
Naples 53
Dong Ket 49
Montreal 47
Casablanca 46
Redmond 45
Vienna 45
Cambridge 44
Denver 42
Nuremberg 41
Tokyo 41
Turku 39
Orem 37
Toronto 36
Haiphong 34
Amsterdam 33
Manchester 33
Atlanta 32
Jacksonville 32
Sydney 32
Bern 31
Udine 31
North Bergen 30
Boydton 29
Chennai 28
Redondo Beach 27
Da Nang 25
Mexico City 25
Phoenix 25
Shanghai 25
Guangzhou 24
Brussels 23
Düsseldorf 23
Redwood City 23
Bremen 22
Paris 22
Berlin 20
Bologna 20
Dakar 20
Florence 20
Genoa 20
Mumbai 20
Palermo 20
Brooklyn 19
Falls Church 19
Rio de Janeiro 19
Wroclaw 19
Campinas 18
Treviso 18
Turin 18
Ankara 17
Baghdad 17
Memphis 17
Stockholm 17
Tashkent 17
Bangkok 16
Istanbul 16
Izmir 16
Jakarta 16
Totale 10.892
Salva come PNG Salva come JPEG
Nome #
Keratin14 mRNA expression in human pneumocytes during quiescence, repair and disease 479
Effect of cystic fibrosis sputum rheology on lungs drug delivery by inhalation 425
Acute respiratory distress syndrome 422
Alveolar Epithelial Type II Cells 396
Potential links between COVID-19-associated pulmonary aspergillosis and bronchiectasis as detected by high resolution computed tomography 391
miR-200 family members reduce senescence and restore idiopathic pulmonary fibrosis type II alveolar epithelial cell transdifferentiation 375
Epithelial⁻Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis 332
Is early detection of late-onset Pompe disease a pneumologist’s affair? A lesson from an Italian screening study 276
Imaging review of the lung parenchymal complications in patients with IPF 244
Deciphering loop gain complexity: a primer for understanding a pathophysiological trait of obstructive sleep apnea patients 234
The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung 215
Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy 213
Chronic Thromboembolic Pulmonary Hypertension: An Update 213
Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows 210
C1q–Ha matrix regulates the local synthesis of hyaluronan in malignant pleural mesothelioma by modulating has3 expression 210
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO) 205
Interstitial lung disease in patients with antisynthetase syndrome: a retrospective case series study 204
Low sensitivity of rapid tests detecting anti-CoV-2 IgG and IgM in health care workers’ serum for COVID-19 screening 204
Radiological-pathological signatures of patients with COVID-19-related pneumomediastinum: is there a role for the Sonic hedgehog and Wnt5a pathways? 203
Use of low field nuclear magnetic resonance to monitor lung inflammation and the amount of pathological components in the sputum of cystic fibrosis patients 200
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone 199
Complement protein C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 198
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat? 197
Laser Speckle Contrast Analysis: Functional Evaluation of Microvascular Damage in Connective Tissue Diseases. Is There Evidence of Correlations With Organ Involvement, Such as Pulmonary Damage? 196
Emergency Laser Treatment of a Tracheobronchial Carcinoid during ECMO 195
Diagnostic Accuracy of Chest Digital Tomosynthesis in Patients Recovering after COVID-19 Pneumonia 193
The Treatment of Lung Involvement in Systemic Sclerosis 189
C1-inhibitor is a novel prognostic factor in malignant pleural mesothelioma and in serous ovarian carcinoma 188
Assessment of Treatment Effects of Aminaphtone by Capillaroscopy in a Patient with Raynaud’s Phenomenon 188
Effect of chest physiotherapy on cystic fibrosis sputum nanostructure: an experimental and theoretical approach 186
Regeneration or Repair? The Role of Alveolar Epithelial Cells in the Pathogenesis of Idiopathic Pulmonary Fibrosis (IPF) 184
A tailored machine learning approach for mortality prediction in severe COVID-19 treated with glucocorticoids 183
184 Complement score: A novel prognostic tool in malignant pleural mesothelioma? 182
Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia 181
179 C1q stimulates hyaluronic acid degradation via gC1qR/HABP1/p32 in malignant pleural mesothelioma 179
Low arousal threshold: a common pathophysiological trait in patients with obstructive sleep apnea syndrome and asthma 178
Children under 5 years are at risk for tuberculosis after occasional contact with highly contagious patients: outbreak from a smear-positive healthcare worker 172
Complement component C1q can predict patients’ response to cisplatin depending on tumour type: A step towards personalized medicine? 168
Severe COVID‐19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail? 168
Transbronchial lung cryobiopsy and pulmonary fibrosis: A never-ending story? 167
High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients 165
Chronic Thromboembolic Pulmonary Hypertension: An Observational Study 164
Il supporto decisionale nei processi di acquisto dei broncoscopi monouso 164
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 163
The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis 161
Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS 159
Clinical Evaluation of the ButterfLife Device for Simultaneous Multiparameter Telemonitoring in Hospital and Home Settings 157
Functional Progression after Dose Suspension or Discontinuation of Nintedanib in Idiopathic Pulmonary Fibrosis: A Real-Life Multicentre Study 157
Hematopoietic Stem Cell Transplantation in Late‐onset X‐linked Chronic Granulomatous Disease in a Female Carrier 155
High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose? 154
Limited role for bronchoalveolar lavage to exclude Covid-19 after negative upper respiratory tract swabs: a multicenter study 152
Vascular Endothelial Damage in COPD: Where Are We Now, Where Will We Go? 150
Evaluation of Correlations between Genetic Variants and High‐Resolution Computed Tomography Patterns in Idiopathic Pulmonary Fibrosis 149
Chronic Obstructive Pulmonary Disease definition: is it time to incorporate also the concept of lung regeneration's failure? 147
Caution When Comparing the Impact of Corticosteroids in COVID-19 144
An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients 144
Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease 143
Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study) 143
Host-Based Treatments for Severe COVID-19 141
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 141
Successful treatment of life-threatening mycobacteriosis using adjunctive gamma-interferon therapy with genetic analysis 141
Interstitial lung disease at high resolution ct after SARS‐COV‐2‐related acute respiratory distress syndrome according to pulmonary segmental anatomy 141
Low Arousal Threshold Estimation Predicts Failure of Mandibular Advancement Devices in Obstructive Sleep Apnea Syndrome 140
Comorbidities’ Effect on IPF: Pathogenesis and Management 139
Calcified Lung Nodules: A Diagnostic Challenge in Clinical Daily Practice 138
Correlation between Microvascular Damage and Internal Organ Involvement in Scleroderma: Focus on Lung Damage and Endothelial Dysfunction 138
Monitoring respiratory mechanics by oscillometry in COVID-19 patients receiving non-invasive respiratory support 138
Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter-A Critical Review and Viewpoints 137
Advances in Diagnostics and Management of Respiratory System Diseases 135
Pulmonary fibrosis: one manifestation, various diseases 134
A novel technique for conducting flexible bronchoscopy cryobiopsy under conscious sedation: An observational study 134
Nailfold Capillaroscopy Analysis Can Add a New Perspective to Biomarker Research in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis 131
Gastrointestinal Manifestations of Sarcoidosis: A State-of-the-Art, Comprehensive Review of the Literature—Practical Clinical Insights and Many Unmet Needs on Diagnosis and Treatment 130
Correlation between Potential Risk Factors and Pulmonary Embolism in Sarcoidosis Patients Timely Treated 130
Nailfold Video-Capillaroscopy in Sarcoidosis: New Perspectives and Challenges 129
Valutazione dei fattori di rischio di embolia polmonare nei pazienti affetti da sarcoidosi 127
Flt1 produced by lung endothelial cells impairs ATII cell transdifferentiation and repair in pulmonary fibrosis 126
OBSTRUCTIVE SLEEP APNEA SYNDROME (OSAS). WHAT’S NEW? 125
Cardiopulmonary exercise testing complements both spirometry and nuclear imaging for assessing sarcoidosis stage and for monitoring disease activity 125
Autoantibodies in sarcoidosis: innocent bystander or promising biomarker for organ involvement? 124
MicroRNA-200 revertono il fenotipo di pneumociti tipo II primari da fibrosi polmonare idiopatica 122
Oscillometry Longitudinal Data on COVID-19 Acute Respiratory Syndrome Treated with Non-Invasive Respiratory Support 122
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension 120
Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant 120
Biomarkers in Systemic Sclerosis: An Overview 119
Pulmonary Sarcoidosis and Immune Dysregulation: A Pilot Study on Possible Correlation 114
Microvascular Alteration in COVID-19 Documented by Nailfold Capillaroscopy 110
Pulmonary Fibrosis: one manifestation, various diseases 107
Monitoraggio degli scambi gassosi e dell’equilibrio acido-base durante ventilazione meccanica 106
Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 104
Monitoring lung mechanics by oscillometry in COVID 19 ARDS receiving non-invasive ventilation: a pilot study 101
The Updated Role of Ultrasound in Assessing Dermatological Manifestations in Systemic Sclerosis 100
Nintedanib Treatment for Idiopathic Pulmonary Fibrosis Patients Who Have Been Switched from Pirfenidone Therapy: A Retrospective Case Series Study 96
Factors limiting the utility of bronchoalveolar lavage in the diagnosis of COVID-19 96
Walking the fine line between OSA and aging 95
CT Imaging Features of Pulmonary Sarcoidosis: Typical and Atypical Radiological Features and Their Differential Diagnosis 94
Epithelial-Mesenchymal Transition: A Major Pathogenic Driver in Idiopathic Pulmonary Fibrosis? 93
What Role Does Trabecular Bone Score Play in Chronic Inflammatory Rheumatic Diseases? 93
Obstructive Sleep Apnea Syndrome in women: gender in sleep respiratory medicine is a first step towards personalized medicine 92
Higher, but Not Too High, Dose Is Only One Determinant of Corticosteroid Treatment Success in Severe COVID-19 90
Totale 17.151
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.256
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.256
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202140 0 0 0 0 0 0 0 0 0 0 0 40
2021/2022885 55 39 69 72 58 52 100 23 126 60 56 175
2022/20231.560 135 204 154 178 115 198 56 135 189 41 108 47
2023/20241.592 93 82 125 112 139 152 315 213 49 86 139 87
2024/20253.342 79 185 236 269 265 255 197 195 407 459 391 404
2025/20269.701 825 526 675 976 747 747 1.319 397 1.055 1.219 770 445
Totale 18.862